Program (draft)

ISDS 2026 – Program at a Glance

17th International Skeletal Dysplasia Society Meeting
Toronto, Ontario, Canada | August 26–29, 2026
Program at a Glance (framework timing and session structure; speakers/topics to be confirmed)

Time	Session / Activity	Notes
Wednesday, August 26, 2026
16:00–18:00	Registration	Arrival / on-site check-in
16:00–17:30	ISDS Workshop	Open to all; e.g., Nosology / data harmonization / ISDS initiatives
18:30–20:30	Welcome Reception	Networking
Thursday, August 27, 2026
08:45–10:30	Session 1: Novel Genes and Phenotypes	Oral scientific presentations
10:30–11:00	Coffee Break
11:00–12:00	Session 2: Functional Characterization	Oral scientific presentations
12:00–12:30	Named Lecture	Keynote / memorial lecture (TBD)
12:30–13:45	Lunch
13:45–14:05	Corporate Symposium	Industry educational symposium (TBD)
14:05–15:35	Session 3: Mouse Models of Skeletal Dysplasias	Oral scientific presentations
15:35–15:50	Coffee Break
15:50–16:50	Poster Session 1	Moderated poster viewing
17:30	Optional Local Visit(s)	Details TBA
Friday, August 28, 2026
08:30–10:30	Session 4: Clinical and Radiological Aspects	Cohorts and cases; oral presentations
10:30–11:00	Coffee Break
11:00–12:00	Poster Session 2	Moderated poster viewing
12:00–13:00	ISDS Business Meeting	Members-only (as applicable)
13:00–14:00	Lunch
14:00–14:20	Corporate Symposium	Industry educational symposium (TBD)
14:20–16:10	Session 5: Novel Treatments and Repurposing of Therapies	Trials, translational science, emerging therapies
16:10–16:40	Coffee Break
16:40–17:25	Session 6: Other Topics	Multidisciplinary and emerging topics
18:30	Conference Dinner	Awards presentation (as applicable)
Saturday, August 29, 2026
09:00–10:45	Session 7: Care and Monitoring of Skeletal Dysplasia Patients	Oral scientific presentations
10:45–11:15	Coffee Break
11:15–13:15	Session 8: Genetic Testing in Skeletal Dysplasias	Oral scientific presentations
13:15–13:30	Awards and Closing Remarks
13:30	Lunch (Boxed / Grab-and-Go)

Planning note: Oral presentations are typically built around 15 minutes including Q&A (confirm for 2026).

---

RCPSC / CPD

Accreditation statement (placeholder):
This activity is planned in accordance with the standards of the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada (RCPSC). This activity is an Accredited Group Learning Activity (Section 1) as defined by the RCPSC MOC Program and approved by the Canadian Association of Pathologists for [#] MOC Section 1 credits.

Disclosures / conflict of interest:
All speakers, moderators, and planning committee members are required to disclose financial and non-financial relationships. Disclosures will be collected in advance and communicated to participants at the start of sessions and/or in program materials. Any conflicts of interest will be mitigated in accordance with RCPSC standards.

Commercial support:
This activity may receive commercial support in the form of educational grants and/or in-kind support. All commercial support will be managed to ensure the scientific integrity and independence of the educational content, in accordance with RCPSC standards.

Educational purpose / needs assessment (placeholder):
The program is informed by identified practice gaps and emerging evidence in the diagnosis, genetics, and management of skeletal dysplasias, including advances in genomics, imaging, clinical monitoring, and therapies. [Insert 2–4 sentence needs assessment summary]